Trial Profile
Phase III long-term administration study of Effexor XR [venlafaxine extended-release] for the treatment of depression
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 23 Jul 2007
Price :
$35
*
At a glance
- Drugs Venlafaxine (Primary)
- Indications Major depressive disorder
- Focus Adverse reactions
- Sponsors Wyeth
- 23 May 2007 Status changed from recruiting to completed.
- 28 Aug 2006 New trial record.